Workflow
Immunovant Announces $450 Million Private Placement
Newsfilter· 2025-01-13 13:00
NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (NASDAQ:IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that it has agreed to sell an aggregate of 22,500,000 shares of common stock at a purchase price of $20.00 per share to three institutional accredited investors in a private investment in public equity (PIPE). Immunovant anticipates receiving aggregate gross proceeds of approximately $450 million from the PIPE. ...
Busch Gardens Unveils 2025 Line-Up of New, Immersive Ride and Realm Coming this Spring
Prnewswire· 2025-01-13 13:00
Become a 2025 Pass Member and be the first to experience the new attractions before they open to the public DOWNLOAD HIGH-RES IMAGES & B-ROLL TAMPA, Fla., Jan. 13, 2025 /PRNewswire/ -- Busch Gardens is thrilled to announce its exciting line-up of all-new rides and realms opening in Spring 2025. Guests to the award-winning Busch Gardens parks in Tampa Bay and Williamsburg can look forward to thrilling and immersive experiences the whole family can enjoy. New attractions include North America's longest invert ...
Nova to Report Fourth Quarter and Full Year 2024 Financial Results on February 13
Prnewswire· 2025-01-13 13:00
Conference call to be held on the same day at 8:30 a.m. Eastern Time REHOVOT, Israel, Jan. 13, 2025 /PRNewswire/ -- Nova (NASDAQ: NVMI), a leading innovator and a key provider of metrology solutions for advanced process control used in semiconductor manufacturing, today announced that it expects to release its financial results for the fourth quarter and full year of 2024 before the Nasdaq market opens on Thursday, February 13, 2025. Q4 and Full Year 2024 Conference Call Details: Gaby Waisman, President and ...
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Newsfilter· 2025-01-13 13:00
Anticipates multiple clinical updates in the next 12-18 months, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of one new asset based on its next generation targeted radiopharmaceutical technology platformFour additional new assets being evaluated for IND development, to be guided by first-in-human imagesMaking progress on plans to expand manufacturing capabilities by improving efficiencies of existing facilities and building out recently acquired sites, w ...
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results
Newsfilter· 2025-01-13 13:00
CLEARWATER, Fla, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported preliminary revenue results for the fourth quarter and full year ended December 31, 2024. Preliminary Fourth Quarter 2024 Revenue Summary: Total revenue expected to be in a range of approximately $14.1 to $14.3 million, representing a decrease of 4% to 3% year-over-year. Advanced ...
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2024
GlobeNewswire· 2025-01-13 13:00
Earnings Announcement and Conference Call - SLR Investment Corp will release its financial results for the quarter and fiscal year ended December 31, 2024 on February 25, 2025 after market close [1] - The company will host an earnings conference call and audio webcast at 10:00 a m Eastern Time on February 26, 2025 [1] - Interested parties can participate in the conference call by dialing (800) 579-2543 for domestic callers or (785) 424-1789 for international callers [2] - The conference call will be broadcast live over the Internet and can be accessed from the Event Calendar within the Investors tab of SLR Investment Corp's website [3] - A telephone replay will be available until March 12, 2025 and can be accessed by dialing (800) 839-4568 for domestic callers or (402) 220-2681 for international callers [2] - A replay of the webcast will be available soon after the call for those unable to listen live [3] Company Overview - SLR Investment Corp is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940 [4] - The company is a specialty finance company with expertise in several niche markets [4] - SLR Investment Corp primarily invests directly and indirectly in leveraged U S middle market companies [4] - The company's investments are primarily in the form of cash flow senior secured loans including first lien and second lien debt instruments [4] - SLR Investment Corp also invests in asset-based loans including senior secured loans collateralized on a first lien basis primarily by current assets [4]
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy
GlobeNewswire· 2025-01-13 13:00
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, is pleased to announce its newest pediatric hospital customer, a nationally ranked hospital in Utah. The hospital, Nuwellis’ 44th pediatric account, will be utilizing the Aquadex SmartFlow® system to treat children suffering from fluid overload caused by kidney and heart disease. Since 2020 when the FDA granted clearance, Nuwellis has inc ...
NANO Nuclear Energy Closes Acquisition of Patented Micro Modular Reactor (MMR®) and Pylon Transportable Reactor Technologies
GlobeNewswire· 2025-01-13 13:00
Figure 1 Renditions of NANO Nuclear Energy’s newly acquired technologies: Pylon for terrestrial (bottom) and space (top) applications and the Modular Micro Reactor (MMR®) Energy System (right). Acquisition immediately adds one of the highest technology readiness level advanced nuclear reactors in development and significantly expands NANO Nuclear’s patent portfolio. Acquisition also brings important contracts, collaboration and adds to existing pipeline of cutting edge small nuclear reactor technologie ...
Enphase Energy Introduces IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Power in Germany, Austria, and Switzerland
GlobeNewswire· 2025-01-13 13:00
FREMONT, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced production shipments of its most powerful and versatile battery yet, the IQ® Battery 5P with FlexPhase, for customers in Germany, Austria, and Switzerland. The IQ Battery 5P with FlexPhase is an all-in-one AC-coupled system that delivers reliable backup power and supports both single-phase ...
VEON to List Kyivstar on Nasdaq in New York, Signs Letter of Intent with Cohen Circle
GlobeNewswire· 2025-01-13 13:00
Kyiv, New York, Dubai and Philadelphia, 13 January 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or, together with its subsidiaries, the “Group”), and Cohen Circle Acquisition Corp. I (“Cohen Circle”), a special purpose acquisition company (Nasdaq: CCIRU), today announced the signing of a letter of intent (“LOI”) to enter into a business combination with the aim of indirectly listing Kyivstar, VEON’s digital operator in Ukraine, on the Nasdaq Stock Market LLC (“Nasdaq”) in the United Sta ...